This section is The content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by GlobeNewswire

TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — PsyCan, the trade association representing Canada’s medical psychedelics industry, is calling for urgent reforms to the way Canadians access psychedelics for medical purposes following a release of Health Canada Special Access Program (SAP) records under the Access to Information Act.

The release shows psilocybin and MDMA approvals dropping dramatically under the Carney government with only half as many SAP requests for psychedelic-assisted therapy being approved compared to last year. Timelines on decisions have also been growing dramatica

See Full Page